TAK Takeda Pharmaceutical Company Limited ADRs

Takeda Pharmaceutical Co Ltd is a pharmaceutical company in Japan. It is primarily focused on four therapeutic areas; oncology, gastroenterology, cardiovascular/metabolic, and neurology. The company markets its products across Europe and emerging markets. This is an ADR of a company whose stock trades outside of the U.S. as the symbol JT:4502.

$17.10  +0.10 (0.56%)
As of 04/14/2021 12:09:23 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Japan
Country of incorporation:  
IPO date:  04/26/2000
Outstanding shares:  3,155,700,240
Average volume:  2,927,062
Market cap:   $53,646,904,080
Current dividend yield:  2.53%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    874060205
ISIN:        US8740602052
Sedol:      
Valuation   (See tab for details)
PE ratio:   32.52
PB ratio:   0.01
PS ratio:   1.82
Return on equity:   3.90%
Net income %:   5.59%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy